Petach Tikva

Nov 28, 2024 | academic.oup.com | Feeding Disorders |Liver Diseases |Petach Tikva

Data on upadacitinib therapy in children with ulcerative colitis (UC) or unclassified inflammatory bowel disease (IBD-U) are scarce. We aimed to evaluate the effectiveness and safety of upadacitinib as an induction therapy in pediatric UC or IBD-U. In this multicenter retrospective study, children treated with upadacitinib for induction of remission of active UC or IBD-U from 30 centers worldwide were enrolled.

Sep 16, 2024 | ijhpr.biomedcentral.com | Petach Tikva

The 2021 Anesthesiology Workforce Survey provided much information on the current composition of the Israeli anesthesiology workforce. Comparing these new data to the 2005 survey highlighted that the workforce is still mainly composed of graduates of non-Israeli medical schools since relatively few Israeli medical school graduates enter the specialty.

Jul 15, 2024 | respiratory-research.biomedcentral.com | Petach Tikva

A retrospective study was performed in adult patients (age ≥18 years) with bronchiectasis who underwent bronchoscopy including NTM cultures between January 2007 and August 2020 at a single tertiary university medical center in Israel. Bronchoscopy was indicated for patients with bronchiectasis exacerbation who failed to respond to empiric therapy and showed no evidence of a pathogen, either due to no sputum production or failure of sputum cultures to grow a pathogen.

May 9, 2024 | bmcpulmmed.biomedcentral.com | Beilinson Campus |Sackler Faculty |Petach Tikva

We conducted a single-center, prospective, single-blinded, randomized, placebo-controlled trial at Rabin Medical Center in Israel between November 2019 and January 2023. The first patient was recruited on 03/11/2019, and the last patient was recruited on 15/01/2023.

Mar 27, 2024 | jamanetwork.com | Yair Zloof |Ramat Gan |Petach Tikva

Primary focal hyperhidrosis is excessive sweating and occurs in 1% of the Israel population to 4.8% of the US population.1,2 Hypermobility spectrum disorder (HSD) and hypermobile Ehlers-Danlos Syndrome (hEDS) are complex noninflammatory connective-tissue disorders manifested by joint hypermobility, musculoskeletal symptoms, and autonomic dysregulation.